Broad-spectrum penicillin-based antibiotics significantly improve outcomes after pancreatoduodenectomy compared to standard care options.

• Surgical site infections dropped by 47% (OR 0.53), and postoperative pancreatic fistula rates decreased by 38% (OR 0.62).
• Patients had shorter hospital stays, averaging 2 days less (MD -2.02).

Implementing broad-spectrum antibiotics could redefine surgical management and reduce complication rates, especially for patients with preoperative biliary drainage.

• In that subgroup, surgical site infections decreased by 55% (OR 0.45) and mortality by 66% (OR 0.34).

Liver transplantation (LT) and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) yield comparable survival outcomes for colorectal liver metastases (CRLM).

• Median overall survival after ALPPS was 76 months vs. 72.7 months for LT.
• After adjusting for biases, ALPPS showed a higher risk of death (HR=1.40), but no significant difference in survival was confirmed (p=0.398).

Consider patient selection carefully: those with failed ALPPS had significantly lower survival rates (31.1 months) compared to LT (p=0.043).

• Outcomes improved for selected ALPPS patients under updated criteria, but LTs not meeting those criteria showed similar results to ALPPS.

Drainage fluid C-reactive protein levels can help predict clinically relevant pancreatic fistulas post-pancreaticoduodenectomy.

• 15.1% of patients developed clinically relevant pancreatic fistulas.
• CRP levels in drainage fluid on postoperative day 4 ≥6.5 mg/dl have an odds ratio of 4.95 for predicting fistulas, with a negative predictive value of 95.6%.

Consider using drain CRP measurements to enhance decision-making for patient management after surgery.

• Serum and drain CRP levels showed strong correlation, indicating that both can be valuable for postoperative assessments.